Meiqi Lu
Overview
Explore the profile of Meiqi Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen C, Yang K, Zhang Y, Lu M, Zhao X, Wan Z
Nutr Diabetes
. 2024 Aug;
14(1):60.
PMID: 39107295
Background: Type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) are prevalent metabolic disorders with overlapping pathophysiological mechanisms. A comprehensive understanding of the shared molecular pathways involved in these...
2.
Wang X, Zhou Y, Chen S, Lu M, Guan C, He R, et al.
Plant Sci
. 2024 Jul;
347:112182.
PMID: 39019090
Photosynthesis is the main source of energy for plants to sustain growth and development. Abnormalities in photosynthesis may cause defects in plant development. The elaborate regulatory mechanism underlying photosynthesis remains...
3.
Deng X, Luo Y, Lu M, Lin Y, Ma L
Heliyon
. 2024 Apr;
10(7):e28997.
PMID: 38601619
Background: IgA nephropathy (IgAN) stands as the most prevalent form of glomerulonephritis and ranks among the leading causes of end-stage renal disease worldwide. Regrettably, we continue to grapple with the...
4.
Chen Y, Lu M, Lin M, Gao Q
Lupus
. 2024 Jan;
33(4):347-356.
PMID: 38285068
Objective: Hydroxychloroquine (HCQ), characterized by a broad effect on immune regulation, has been widely used in the treatment of autoimmune glomerulonephritis such as lupus nephritis (LN) and immunoglobulin A nephropathy...
5.
Xie W, Zhang Y, Tang J, Zhu X, Wang S, Lu M
Integr Cancer Ther
. 2024 Jan;
23:15347354231225961.
PMID: 38229425
Background: In China, traditional Chinese medicines (TCMs), as a complementary therapy combined with chemotherapy, is widely used in the treatment of gastric cancer (GC). In order to systematically evaluate and...
6.
Chen C, Zhang H, Lin Y, Lu M, Liao Q, Zhang S, et al.
Immun Inflamm Dis
. 2023 Nov;
11(11):e1087.
PMID: 38018597
Objective: Systemic lupus erythematosus (SLE) patients are at risk during the COVID-19 pandemic, yet the underlying molecular mechanisms remain incompletely understood. This study sought to analyze the potential molecular connections...
7.
Lu M, Ou J, Deng X, Chen Y, Gao Q
Heliyon
. 2023 Jul;
9(6):e17550.
PMID: 37416640
Background: (TW), when formulated in traditional Chinese medicine (TCM), can effectively treat diabetic kidney disease (DKD). However, the pharmacological mechanism associated with its success has not yet been elucidated. The...
8.
Lu M, Wang X, Gong H, Shao M, Yu J, Wang X, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
. 2023 Mar;
35(3):334-336.
PMID: 36916351
Brain edema could be secondary to cerebral lesion caused by a variety of reasons, severe cases may result in brain herniation or even death. Accurate real-time monitoring of cerebral edema,...
9.
Wang X, Zhao J, Wang X, Zhang J, Wang Y, Wang X, et al.
Front Surg
. 2023 Feb;
9:1027067.
PMID: 36726958
Objective: The bacterial cellulose membrane (BCM) has been widely studied and applied as a new biomaterial for wound healing, but causes pain with frequent dressing changes. Local application of bone...
10.
Chen Y, Lu M, Feng Y, Gao Q
Medicine (Baltimore)
. 2023 Jan;
101(52):e32504.
PMID: 36596065
Background: This review aims to assess the efficacy and safety of low-dose Tripterygium wilfordii Hook F (TWHF) in treating type 2 diabetic nephropathy (DN) and provide high-level evidence supporting its...